based on a specific dosage / administration regimen

Industry

CPC
C12N2320/35

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2320/00Applications Uses

Current Industry

C12N2320/35based on a specific dosage / administration regimen

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
- Patent number 12,215,321
- Issue date Feb 4, 2025
- Ionis Pharmaceuticals, Inc.
- Eric E. Swayze
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulators of APOL1 expression
- Patent number 12,168,766
- Issue date Dec 17, 2024
- Astrazeneca AB
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
DNA-PK inhibitors
- Patent number 12,121,524
- Issue date Oct 22, 2024
- Vertex Pharmaceuticals Incorporated
- Marc Saul Weinberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Selective reduction of allelic variants
- Patent number 12,110,491
- Issue date Oct 8, 2024
- Ionis Pharmaceuticals, Inc.
- C. Frank Bennett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted inhibition using engineered oligonucleotides
- Patent number 12,104,157
- Issue date Oct 1, 2024
- MIRECULE, INC.
- Robert Place
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi agents for inhibiting expression of PNPLA3, pharmaceutical com...
- Patent number 12,054,718
- Issue date Aug 6, 2024
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Liposomal system for drug delivery
- Patent number 12,036,282
- Issue date Jul 16, 2024
- Newsouth Innovations Pty Limited
- Ewa Goldys
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for immunooncology
- Patent number 12,037,583
- Issue date Jul 16, 2024
- Novartis AG
- Ming-Wei Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for detection of SMN protein in a subject...
- Patent number 12,013,403
- Issue date Jun 18, 2024
- Biogen MA Inc.
- Frank Rigo
- G01 - MEASURING TESTING
Information Patent Grant
Combination therapy with liposomal antisense oligonucleotides
- Patent number 12,012,601
- Issue date Jun 18, 2024
- BIO-PATH HOLDINGS, INC.
- Ana Tari Ashizawa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for inhibiting expression of the LECT2 gene
- Patent number 11,987,792
- Issue date May 21, 2024
- Alnylam Pharmaceuticals, Inc.
- Gregory Hinkle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for genome editing in non-dividing cells
- Patent number 11,959,094
- Issue date Apr 16, 2024
- Salk Institute for Biological Studies
- Juan Carlos Izpisua Belmonte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating multiple sclerosis using antisense oligonucleo...
- Patent number 11,891,606
- Issue date Feb 6, 2024
- Antisense Therapeutics Ltd
- George Tachas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligomers for treatment of conditions and diseases
- Patent number 11,873,490
- Issue date Jan 16, 2024
- Stoke Therapeutics, Inc.
- Isabel Aznarez
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapy specific, pre-programmed auto injection device
- Patent number 11,850,374
- Issue date Dec 26, 2023
- ALCYONE THERAPEUTICS, INC.
- P J Anand
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulation of prekallikrein (PKK) expression
- Patent number 11,840,686
- Issue date Dec 12, 2023
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dosages and methods for delivering lipid formulated nucleic acid mo...
- Patent number 11,827,883
- Issue date Nov 28, 2023
- Alnylam Pharmaceuticals, Inc.
- Pia Kasperkovitz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating transthyretin (TTR) mediated...
- Patent number 11,806,360
- Issue date Nov 7, 2023
- Alnylam Pharmaceuticals, Inc.
- Jared Gollob
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted inhibition using engineered oligonucleotides
- Patent number 11,795,459
- Issue date Oct 24, 2023
- MIRECULE, INC.
- Robert Place
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapy
- Patent number 11,795,462
- Issue date Oct 24, 2023
- Index Pharmaceuticals AB
- Arezou Zargari
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligomers
- Patent number 11,697,811
- Issue date Jul 11, 2023
- Royal Holloway, University of London
- Linda Popplewell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for genome editing in non-dividing cells
- Patent number 11,674,158
- Issue date Jun 13, 2023
- Salk Institute for Biological Studies
- Juan Carlos Izpisua Belmonte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNA interference agents for GST-PI gene modulation
- Patent number RE49431
- Issue date Feb 28, 2023
- Nitto Denko Corporation
- Kenjirou Minomi
Information Patent Grant
Methods and formulations for the treatment of obesity and obesity-r...
- Patent number 11,578,325
- Issue date Feb 14, 2023
- David Berz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulators of APOL1 expression
- Patent number 11,525,136
- Issue date Dec 13, 2022
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds and compositions including phosphorothioated oligodeoxynu...
- Patent number 11,464,865
- Issue date Oct 11, 2022
- City of Hope
- Marcin Tomasz Kortylewski
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for treating malignant tumors associated w...
- Patent number RE49229
- Issue date Oct 4, 2022
- Nitto Denko Corporation
- Kenjirou Minomi
Information Patent Grant
Oligonucleotides for the treatment of nucleotide repeat expansion d...
- Patent number 11,408,000
- Issue date Aug 9, 2022
- Triplet Therapeutics, Inc.
- Nessan Anthony Bermingham
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treating a localized fibrotic disorder using an IL-33 ant...
- Patent number 11,400,154
- Issue date Aug 2, 2022
- 180 Therapeutics LP
- Glenn Larsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Exon skipping oligomer conjugates for muscular dystrophy
- Patent number 11,382,981
- Issue date Jul 12, 2022
- Sarepta Therapeutics, Inc.
- Marco A. Passini
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
RNAi Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Com...
- Publication number 20250034577
- Publication date Jan 30, 2025
- Arrowhead Pharmaceuticals, Inc.
- Anthony Nicholas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Subcutaneous Delivery of RNAi Agents for Inhibiting Expression of R...
- Publication number 20250034578
- Publication date Jan 30, 2025
- Arrowhead Pharmaceuticals, Inc.
- James C. Hamilton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE
- Publication number 20250019699
- Publication date Jan 16, 2025
- Alnylam Pharmaceuticals, Inc.
- Gregory Hinkle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and Methods Using CPG Oligonucleotides
- Publication number 20250002922
- Publication date Jan 2, 2025
- Six Therapeutics Inc.
- Howard LEVINE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20240417722
- Publication date Dec 19, 2024
- Novartis AG
- Ming-Wei CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR GENOME EDITING
- Publication number 20240409961
- Publication date Dec 12, 2024
- Salk Institute for Biological Studies
- Juan Carlos IZPISUA BELMONTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MICRORNA-29 COMPOUNDS, COMPOSITIONS AND USES IN THERAPY
- Publication number 20240390410
- Publication date Nov 28, 2024
- Derek Steward Gilchrist
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CANCER-SPECIFIC TRANS-SPLICING RIBOZYME AS GENE THERAPY PRODUCT COM...
- Publication number 20240368603
- Publication date Nov 7, 2024
- Rznomics Inc.
- Seong-Wook LEE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEG...
- Publication number 20240336934
- Publication date Oct 10, 2024
- The Johns Hopkins University
- Vinod Jaskula-Ranga
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF ENaC EXPRESSION
- Publication number 20240327838
- Publication date Oct 3, 2024
- Ionis Pharmaceuticals, Inc.
- Jeffrey R. Crosby
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODULATION OF PREKALLIKREIN (PKK) EXPRESSION
- Publication number 20240318183
- Publication date Sep 26, 2024
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY
- Publication number 20240318182
- Publication date Sep 26, 2024
- Biogen MA Inc.
- Kenneth Swope Loveday
- G01 - MEASURING TESTING
Information Patent Application
COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREO...
- Publication number 20240301406
- Publication date Sep 12, 2024
- Alnylam Pharmaceuticals, Inc.
- Nader Najafian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES T...
- Publication number 20240293563
- Publication date Sep 5, 2024
- AstraZeneca AB
- Brett P. MONIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATING APOLIPOPROTEIN (A) EXPRESSION
- Publication number 20240218361
- Publication date Jul 4, 2024
- Ionis Pharmaceuticals, Inc.
- Nicholas J. Viney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE...
- Publication number 20240200075
- Publication date Jun 20, 2024
- Alnylam Pharmaceuticals, Inc.
- William Querbes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONU...
- Publication number 20240189434
- Publication date Jun 13, 2024
- PepGen Inc.
- Caroline GODFREY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MO...
- Publication number 20240175024
- Publication date May 30, 2024
- Alnylam Pharmaceuticals, Inc.
- Pia Kasperkovitz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20240175017
- Publication date May 30, 2024
- Alnylam Pharmaceuticals, Inc.
- Anna Borodovsky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY...
- Publication number 20240167034
- Publication date May 23, 2024
- University of Rochester
- Steven A. GOLDMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Composition Comprising Antisense Oligonucleotide and Use Thereof fo...
- Publication number 20240158792
- Publication date May 16, 2024
- NIPPON SHINYAKU CO., LTD.
- Tomonori UNO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES
- Publication number 20240150760
- Publication date May 9, 2024
- Stoke Therapeutics, Inc.
- Isabel AZNAREZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR THE TREATMENT OF NASH WITH ADVANCED FIBROSIS AND/OR CIR...
- Publication number 20240150768
- Publication date May 9, 2024
- Boehringer Ingelheim International GmbH
- Ingo UPHUES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED INHIBITION USING ENGINEERED OLIGONUCLEOTIDES
- Publication number 20240141346
- Publication date May 2, 2024
- miRecule, Inc.
- Robert PLACE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TR...
- Publication number 20240100080
- Publication date Mar 28, 2024
- Alnylam Pharmaceuticals, Inc.
- Amy Chan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (P...
- Publication number 20240102020
- Publication date Mar 28, 2024
- Alnylam Pharmaceuticals, Inc.
- Gregory Hinkle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TGF-BETA THERAPEUTICS FOR AGE DISEASE
- Publication number 20240093198
- Publication date Mar 21, 2024
- Vuong TRIEU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED...
- Publication number 20240075052
- Publication date Mar 7, 2024
- Alnylam Pharmaceuticals, Inc.
- Jared A. Gollob
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NEW THERAPY
- Publication number 20240043847
- Publication date Feb 8, 2024
- INDEX PHARMACEUTICALS AB
- Arezou Zargari
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY
- Publication number 20240041757
- Publication date Feb 8, 2024
- CRISPR Therapeutics AG
- Seshidhar Reddy Police
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

based on a specific dosage / administration regimen

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Modulators of diacyglycerol acyltransferase 2 (DGAT2)

Modulators of APOL1 expression

DNA-PK inhibitors

Selective reduction of allelic variants

Targeted inhibition using engineered oligonucleotides

RNAi agents for inhibiting expression of PNPLA3, pharmaceutical com...

Liposomal system for drug delivery

Compositions and methods for immunooncology

Compositions and methods for detection of SMN protein in a subject...

Combination therapy with liposomal antisense oligonucleotides

Compositions and methods for inhibiting expression of the LECT2 gene

Methods and compositions for genome editing in non-dividing cells

Methods for treating multiple sclerosis using antisense oligonucleo...

Antisense oligomers for treatment of conditions and diseases

Therapy specific, pre-programmed auto injection device

Modulation of prekallikrein (PKK) expression

Dosages and methods for delivering lipid formulated nucleic acid mo...

Compositions and methods for treating transthyretin (TTR) mediated...

Targeted inhibition using engineered oligonucleotides

Therapy

Oligomers

Methods and compositions for genome editing in non-dividing cells

RNA interference agents for GST-PI gene modulation

Methods and formulations for the treatment of obesity and obesity-r...

Modulators of APOL1 expression

Compounds and compositions including phosphorothioated oligodeoxynu...

Methods and compositions for treating malignant tumors associated w...

Oligonucleotides for the treatment of nucleotide repeat expansion d...

Method of treating a localized fibrotic disorder using an IL-33 ant...

Exon skipping oligomer conjugates for muscular dystrophy

Patents Applicationslast 30 patents

RNAi Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Com...

Subcutaneous Delivery of RNAi Agents for Inhibiting Expression of R...

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

Compositions and Methods Using CPG Oligonucleotides

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

METHODS AND COMPOSITIONS FOR GENOME EDITING

MICRORNA-29 COMPOUNDS, COMPOSITIONS AND USES IN THERAPY

CANCER-SPECIFIC TRANS-SPLICING RIBOZYME AS GENE THERAPY PRODUCT COM...

CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEG...

MODULATORS OF ENaC EXPRESSION

MODULATION OF PREKALLIKREIN (PKK) EXPRESSION

METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREO...

GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES T...

MODULATING APOLIPOPROTEIN (A) EXPRESSION

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE...

METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONU...

DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MO...

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY...

Composition Comprising Antisense Oligonucleotide and Use Thereof fo...

ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES

METHODS FOR THE TREATMENT OF NASH WITH ADVANCED FIBROSIS AND/OR CIR...

TARGETED INHIBITION USING ENGINEERED OLIGONUCLEOTIDES

METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TR...

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (P...

TGF-BETA THERAPEUTICS FOR AGE DISEASE

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED...

NEW THERAPY

LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERY